RUBCNL and ovarian cancer: Moreover, pioneering studies employing retroviral transduction of Zinc-finger proteins engineered with TET-2-CD have shown reactivation of candidate TSGs, such as C13ORF18 and TFPI2 in cervical cancer cells [70], and ICAM-1 in ovarian cancer cells [71].